Non-transferrin-bound iron in myelodysplastic syndromes: a marker of ineffective erythropoiesis? 2000

A Cortelezzi, and C Cattaneo, and S Cristiani, and L Duca, and B Sarina, and G L Deliliers, and G Fiorelli, and M D Cappellini
Servizio Autonomo di Ematologia Diagnostica, Ospedale Maggiore, IRCCS, Milano, Italy. cortelez@polic.cilea.it

BACKGROUND Iron overload is usually observed in patients (even untransfused) with myelodysplastic syndromes (MDS), and contributes towards the generation of low molecular weight iron complexes or non-transferrin-bound iron (NTBI), which in turn favors oxidative DNA damage and consequent apoptosis. METHODS Levels of NTBI and lipid peroxidation were evaluated by means of free serum malondyaldehyde (MDA) in untransfused MDS patients and we tried to correlate them with ineffective erythropoiesis, apoptosis and the pattern of in vitro growth. RESULTS NTBI levels were found to be significantly higher in low-risk than in high-risk MDS patients, as well as in patients with a lower myeloid/erythroid ratio. MDA was found to be uniformly higher in the MDS patients as a whole than in normal controls. The bone marrow progenitor cells in the MDS patients with high NTBI levels showed a higher degree of apoptosis, but this difference was not statistically significant. Patients with a leukemic growth pattern had lower NTBI levels than those with a non-leukemic pattern. CONCLUSIONS These data suggest that NTBI is related to the degree of ineffective erythropoiesis and that it contributes towards inducing apoptosis in MDS bone marrow precursors. The presence of leukemic growth is associated with low NTBI levels, probably due to increased iron consumption by blast cells.

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008297 Male Males
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D009190 Myelodysplastic Syndromes Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA. Dysmyelopoietic Syndromes,Hematopoetic Myelodysplasia,Dysmyelopoietic Syndrome,Hematopoetic Myelodysplasias,Myelodysplasia, Hematopoetic,Myelodysplasias, Hematopoetic,Myelodysplastic Syndrome,Syndrome, Dysmyelopoietic,Syndrome, Myelodysplastic,Syndromes, Dysmyelopoietic,Syndromes, Myelodysplastic
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D003114 Colony-Forming Units Assay A cytologic technique for measuring the functional capacity of stem cells by assaying their activity. Clonogenic Cell Assay,Stem Cell Assay,Clonogenic Cell Assays,Colony Forming Units Assays,Colony-Forming Units Assays,Stem Cell Assays,Assay, Clonogenic Cell,Assay, Colony-Forming Units,Assay, Stem Cell,Assays, Clonogenic Cell,Assays, Colony-Forming Units,Assays, Stem Cell,Colony Forming Units Assay
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries

Related Publications

A Cortelezzi, and C Cattaneo, and S Cristiani, and L Duca, and B Sarina, and G L Deliliers, and G Fiorelli, and M D Cappellini
July 1995, Leukemia & lymphoma,
A Cortelezzi, and C Cattaneo, and S Cristiani, and L Duca, and B Sarina, and G L Deliliers, and G Fiorelli, and M D Cappellini
January 2018, [Rinsho ketsueki] The Japanese journal of clinical hematology,
A Cortelezzi, and C Cattaneo, and S Cristiani, and L Duca, and B Sarina, and G L Deliliers, and G Fiorelli, and M D Cappellini
December 2023, eLife,
A Cortelezzi, and C Cattaneo, and S Cristiani, and L Duca, and B Sarina, and G L Deliliers, and G Fiorelli, and M D Cappellini
June 2022, Clinica chimica acta; international journal of clinical chemistry,
A Cortelezzi, and C Cattaneo, and S Cristiani, and L Duca, and B Sarina, and G L Deliliers, and G Fiorelli, and M D Cappellini
March 2019, Free radical biology & medicine,
A Cortelezzi, and C Cattaneo, and S Cristiani, and L Duca, and B Sarina, and G L Deliliers, and G Fiorelli, and M D Cappellini
September 2023, bioRxiv : the preprint server for biology,
A Cortelezzi, and C Cattaneo, and S Cristiani, and L Duca, and B Sarina, and G L Deliliers, and G Fiorelli, and M D Cappellini
May 2015, Haematologica,
A Cortelezzi, and C Cattaneo, and S Cristiani, and L Duca, and B Sarina, and G L Deliliers, and G Fiorelli, and M D Cappellini
February 2008, Journal of hepatology,
A Cortelezzi, and C Cattaneo, and S Cristiani, and L Duca, and B Sarina, and G L Deliliers, and G Fiorelli, and M D Cappellini
November 1991, Journal of clinical pathology,
A Cortelezzi, and C Cattaneo, and S Cristiani, and L Duca, and B Sarina, and G L Deliliers, and G Fiorelli, and M D Cappellini
May 2007, Toxicology and applied pharmacology,
Copied contents to your clipboard!